Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Lisa M Keder"'
Autor:
Ushma D Upadhyay, Nicole E Johns, Sarah L Combellick, Julia E Kohn, Lisa M Keder, Sarah C M Roberts
Publikováno v:
PLoS Medicine, Vol 13, Iss 8, p e1002110 (2016)
In February 2011, an Ohio law took effect mandating use of the United States Food and Drug Administration (FDA)-approved protocol for mifepristone, which is used with misoprostol for medication abortion. Other state legislatures have passed or enacte
Externí odkaz:
https://doaj.org/article/e47792bad9354d9999ca7fc9398b73b2
Publikováno v:
Contraception. 104:383-387
Objectives We sought to quantify the prevalence of ever attendance at a crisis pregnancy center (CPC) among adult, reproductive-age women in Ohio and identify demographic factors associated with ever attendance. Study Design We analyzed data from the
Autor:
Kaiting Lang, Michelle L. McGowan, Carolette Norwood, B. Jessie Hill, Payal Chakraborty, Mikaela H. Smith, Molly Broscoe, Danielle Bessett, Alison Norris, Lisa M. Keder, Robert B. Hood, Sarah R. Hayford
Publikováno v:
Am J Public Health
Objectives. To examine abortion utilization in Ohio from 2010 to 2018, a period when more than 15 abortion-related laws became effective. Methods. We evaluated changes in abortion rates and ratios examining gestation, geographic distribution, and abo
Autor:
Stephanie B. Teal, Carolyn Westhoff, Lisa M. Keder, Andrea I. Olariu, Mitchell D. Creinin, A. Gangestad
Publikováno v:
Contraception, vol 101, iss 3
Objective To assess 6-year contraceptive efficacy and safety of a levonorgestrel 52 mg intrauterine system (IUS). Study Design We assessed pregnancy rates through 72 months in women aged 16–35 years at enrollment and safety in all participants (age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0eec66ccf6d92d89d6c24ffca2ead55
https://escholarship.org/uc/item/5kr8h999
https://escholarship.org/uc/item/5kr8h999
Autor:
Courtney A, Schreiber, Stephanie B, Teal, Paul D, Blumenthal, Lisa M, Keder, Andrea I, Olariu, Mitchell D, Creinin
Publikováno v:
The European journal of contraceptionreproductive health care : the official journal of the European Society of Contraception. 23(2)
Evaluate bleeding patterns for the LilettaThis prospective multicenter trial evaluates the efficacy and safety of LilettaAmenorrhea rates at 1 and 3 years in levonorgestrel 52 mg IUS users were 19 and 37%, respectively. The infrequent bleeding rate i
Autor:
Lisa M. Keder, Carolyn Westhoff, Andrea I. Olariu, A. Gangestad, Stephanie B. Teal, Mitchell D. Creinin
Publikováno v:
Obstetrics & Gynecology. 133:143S-144S
Publikováno v:
Reproductive Health
Background Few postpartum women use effective contraception and those who use less effective methods have increased rates of unintended pregnancy. Little is known about postpartum contraception intentions among breastfeeding women. Our objectives wer
Publikováno v:
Obstetrics & Gynecology. 133:204S-204S
Milk expression has become common, but little is known about women's intentions and motivations for pumping. Our objectives were to measure, among newly postpartum women, intentions related to breast milk feeding and pumping, reasons for intending to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0b5eb0c625ada1d077f72759bd513fb
https://europepmc.org/articles/PMC5220526/
https://europepmc.org/articles/PMC5220526/
Autor:
Nicole E. Johns, Sarah Combellick, Julia E. Kohn, Lisa M. Keder, Sarah C. M. Roberts, Ushma D. Upadhyay
Publikováno v:
PLoS Medicine, Vol 13, Iss 8, p e1002110 (2016)
PLoS medicine, vol 13, iss 8
Upadhyay, UD; Johns, NE; Combellick, SL; Kohn, JE; Keder, LM; & Roberts, SCM. (2016). Comparison of Outcomes before and after Ohio's Law Mandating Use of the FDA-Approved Protocol for Medication Abortion: A Retrospective Cohort Study. PLoS Medicine, 13(8). doi: 10.1371/journal.pmed.1002110. UCSF: Retrieved from: http://www.escholarship.org/uc/item/3nq1j8rg
PLoS Medicine
PLoS medicine, vol 13, iss 8
Upadhyay, UD; Johns, NE; Combellick, SL; Kohn, JE; Keder, LM; & Roberts, SCM. (2016). Comparison of Outcomes before and after Ohio's Law Mandating Use of the FDA-Approved Protocol for Medication Abortion: A Retrospective Cohort Study. PLoS Medicine, 13(8). doi: 10.1371/journal.pmed.1002110. UCSF: Retrieved from: http://www.escholarship.org/uc/item/3nq1j8rg
PLoS Medicine
Background In February 2011, an Ohio law took effect mandating use of the United States Food and Drug Administration (FDA)-approved protocol for mifepristone, which is used with misoprostol for medication abortion. Other state legislatures have passe